World & BusinessBioNTech's planned deal with Arife reportedly in jeopardy
Handelsblatt says founders Şahin and Türeci want a fresh start with Arife, but their split from BioNTech has sparked tensions over patents, money and employees' futures.
TLDR
Handelsblatt reports that the planned deal between BioNTech and Arife, the new company of founders Şahin and Türeci, is in doubt. The outlet says relations between Uğur Şahin and the rest of BioNTech's leadership have cooled, while the split raises issues over patents, money and employees' futures.
BioNTech's planned deal with Arife reportedly in jeopardy
Handelsblatt says founders Şahin and Türeci want a fresh start with Arife, but their split from BioNTech has sparked tensions over patents, money and employees' futures.
TLDR
Handelsblatt reports that the planned deal between BioNTech and Arife, the new company of founders Şahin and Türeci, is in doubt. The outlet says relations between Uğur Şahin and the rest of BioNTech's leadership have cooled, while the split raises issues over patents, money and employees' futures.